Skip to main content
Caplight Logo









Pluto Biosciences

Pluto Biosciences

Private
Denver, ColoradoHealthcare & Life Scienceshttps://pluto.bio/

Last Round

VC Round

May 13, 2025

Total Funding Raised

$4.7M

Company Overview

Pluto Biosciences is a life sciences company that provides a cloud-based, collaborative platform for managing, analyzing, and visualizing complex biological data without the need for coding.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Vertical SaaS, Data Visualization, Low-Code/No-Code

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

bioinformatics softwaremulti-omicsno-code bioinformaticsdrug discovery softwarescientific data visualizationAI research assistantbioinformatics platformlab informaticstranslational researchAI copilotvertical SaaSdata silosbio-tech stackvibe coding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pluto Biosciences Comparables

Compare Pluto Biosciences with similar companies based on industry and business-model similarity.

Pluto Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rosalind
91%
BigOmics Analytics
88%
Watershed
87%

Pluto Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 13, 2025
SeedMay 2, 2023
SeedOct 12, 2021

Key People

Founding team and executive leadership

Rani Powers

Founder & CEO

Founding Team

Pluto Biosciences Investors

Notable investors and investment history

Pluto Biosciences investors
InvestorRounds
Kickstart FundSeed, VC Round
KickstartVC Round
Silverton PartnersVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 2, 2023

    $4M round led by Silverton Partners

  • Oct 12, 2021

    $1M round with participation from Chris Glodé.

Pluto Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pluto Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pluto Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range25
Year Founded2020
Last FundingMay 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?